-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The fifth batch of nationally organized drug centralized procurement of 61 types of drugs to be purchased was successfully purchased, with an average price reduction of 56%.
The centralized procurement varieties covered drugs for common diseases such as hypertension, coronary heart disease, diabetes, and digestive tract diseases, as well as drugs for chronic diseases, as well as lung cancer and breast.
Drugs for major diseases such as cancer and colorectal cancer
.
It is reported that starting from 0:00 on October 9, the results of the fifth batch of national centralized procurement will be officially implemented in Guangdong Province
.
Patients can purchase 61 medicines with an average decrease of 55% at the selected prices in public medical institutions in the province, and the decrease can reach as high as 98%
.
It is estimated that the cost of medicines will be saved by 1.
982 billion yuan in the first year, benefiting the majority of patients
.
In this centralized procurement, 16 varieties dropped by more than 90%.
Among them, Jiangsu Hausen's gemcitabine hydrochloride for injection (1g) and other 6 companies' products dropped by more than 97%
.
Take bendamustine hydrochloride (100mg) for injection in the Netherlands as an example of the anti-tumor drug.
After the price cut, the cost of each injection will be reduced from 6000 yuan/bottle to 786 yuan/bottle, which can be saved based on the longest 8 cycles.
The patient's cost is about 160,000 yuan
.
In addition to the sharp price reduction of the selected products, Guangdong also linked the prices of non-selected drugs with the same generic names.
For example, more than 10 drugs such as fasudil hydrochloride injection have also fallen sharply, with an average reduction of 70% and a maximum reduction of 98.
%
.
In the next step, Guangdong Province will also speed up the pace of procurement by the inter-provincial alliance, and will launch a batch of selected drugs with a larger scale, more variety and wider coverage before the end of the year, so that the people can enjoy better quality and affordable medical services
.
In addition to the fact that Guangdong Province has officially implemented the fifth batch of national centralized procurement results, Henan, Tibet, Hebei, and Chongqing all began to implement the fifth batch of national procurement from October 1
.
In addition, Shandong, Guizhou, Gansu, Heilongjiang and other provinces are also about to implement the fifth batch of national procurement
.
For example, Shandong Province recently issued the "Notice on the Implementation of the Results of the Fifth Batch of National Organizations' Centralized Purchase of Drugs", requiring all public medical institutions and military medical institutions in Shandong Province to participate in voluntary participation from October 15, 2021.
Medical insurance designated social medical institutions, medical insurance designated retail pharmacies, according to the results of the fifth batch of national organizations to purchase drugs (Shandong), and sell the selected drugs to patients
.
Guizhou Province also recently issued the "Notice on Doing a Good Job in the Implementation of the Results of the Fifth Batch of National-Organized Drug Centralized Procurements", clarifying that the results of the fifth batch of centralized procurement will be implemented on October 15, 2021
.
The documents show that the selected companies must first establish distribution relationships on the platform and independently entrust companies with excellent distribution performance to establish distribution relationships.
In principle, there are no less than 2 companies in each city (autonomous prefecture), and the distribution area can cover all participating purchases.
Medical institutions
.
Medical institutions will place orders for purchases from October 15th
.
Gansu Province issued a notice clarifying that the province will implement the fifth batch of national centralized procurement results from October 15, but the document also pointed out that the current inventory can be digested until November 15, 2021
.
This arrangement gives medical institutions one month to digest the previous inventory.
That is to say, on October 15 at the earliest and November 15 at the latest, Gansu will fully implement the fifth batch of centralized procurement results
.
Heilongjiang Province also recently announced that it will implement the fifth batch of national procurement results in Heilongjiang Province from October 20, 2021.
At the same time, it will also implement the "Eight Provinces and Two Districts" Inter-Provincial Alliance Drug Centralized Procurement Selection.
Result
.
As many places have clarified the implementation time of the fifth batch of national sourcing, the industry said that the fifth batch of national sourcing will soon be implemented nationwide
.
At present, the first five batches of national procurement have covered 218 varieties, and the special national procurement of insulin has also been officially launched
.
It is reported that according to the main indicators for the development of universal medical security during the "14th Five-Year Plan" period, by 2025, the number of drugs purchased in a centralized manner is expected to exceed 500
.
The centralized procurement varieties covered drugs for common diseases such as hypertension, coronary heart disease, diabetes, and digestive tract diseases, as well as drugs for chronic diseases, as well as lung cancer and breast.
Drugs for major diseases such as cancer and colorectal cancer
.
It is reported that starting from 0:00 on October 9, the results of the fifth batch of national centralized procurement will be officially implemented in Guangdong Province
.
Patients can purchase 61 medicines with an average decrease of 55% at the selected prices in public medical institutions in the province, and the decrease can reach as high as 98%
.
It is estimated that the cost of medicines will be saved by 1.
982 billion yuan in the first year, benefiting the majority of patients
.
In this centralized procurement, 16 varieties dropped by more than 90%.
Among them, Jiangsu Hausen's gemcitabine hydrochloride for injection (1g) and other 6 companies' products dropped by more than 97%
.
Take bendamustine hydrochloride (100mg) for injection in the Netherlands as an example of the anti-tumor drug.
After the price cut, the cost of each injection will be reduced from 6000 yuan/bottle to 786 yuan/bottle, which can be saved based on the longest 8 cycles.
The patient's cost is about 160,000 yuan
.
In addition to the sharp price reduction of the selected products, Guangdong also linked the prices of non-selected drugs with the same generic names.
For example, more than 10 drugs such as fasudil hydrochloride injection have also fallen sharply, with an average reduction of 70% and a maximum reduction of 98.
%
.
In the next step, Guangdong Province will also speed up the pace of procurement by the inter-provincial alliance, and will launch a batch of selected drugs with a larger scale, more variety and wider coverage before the end of the year, so that the people can enjoy better quality and affordable medical services
.
In addition to the fact that Guangdong Province has officially implemented the fifth batch of national centralized procurement results, Henan, Tibet, Hebei, and Chongqing all began to implement the fifth batch of national procurement from October 1
.
In addition, Shandong, Guizhou, Gansu, Heilongjiang and other provinces are also about to implement the fifth batch of national procurement
.
For example, Shandong Province recently issued the "Notice on the Implementation of the Results of the Fifth Batch of National Organizations' Centralized Purchase of Drugs", requiring all public medical institutions and military medical institutions in Shandong Province to participate in voluntary participation from October 15, 2021.
Medical insurance designated social medical institutions, medical insurance designated retail pharmacies, according to the results of the fifth batch of national organizations to purchase drugs (Shandong), and sell the selected drugs to patients
.
Guizhou Province also recently issued the "Notice on Doing a Good Job in the Implementation of the Results of the Fifth Batch of National-Organized Drug Centralized Procurements", clarifying that the results of the fifth batch of centralized procurement will be implemented on October 15, 2021
.
The documents show that the selected companies must first establish distribution relationships on the platform and independently entrust companies with excellent distribution performance to establish distribution relationships.
In principle, there are no less than 2 companies in each city (autonomous prefecture), and the distribution area can cover all participating purchases.
Medical institutions
.
Medical institutions will place orders for purchases from October 15th
.
Gansu Province issued a notice clarifying that the province will implement the fifth batch of national centralized procurement results from October 15, but the document also pointed out that the current inventory can be digested until November 15, 2021
.
This arrangement gives medical institutions one month to digest the previous inventory.
That is to say, on October 15 at the earliest and November 15 at the latest, Gansu will fully implement the fifth batch of centralized procurement results
.
Heilongjiang Province also recently announced that it will implement the fifth batch of national procurement results in Heilongjiang Province from October 20, 2021.
At the same time, it will also implement the "Eight Provinces and Two Districts" Inter-Provincial Alliance Drug Centralized Procurement Selection.
Result
.
As many places have clarified the implementation time of the fifth batch of national sourcing, the industry said that the fifth batch of national sourcing will soon be implemented nationwide
.
At present, the first five batches of national procurement have covered 218 varieties, and the special national procurement of insulin has also been officially launched
.
It is reported that according to the main indicators for the development of universal medical security during the "14th Five-Year Plan" period, by 2025, the number of drugs purchased in a centralized manner is expected to exceed 500
.